17-07-2026 17:42 via drugs.com

AAIC: Blood Test Detecting p-tau217 Levels Can Predict Progression to Cognitive Impairment

FRIDAY, July 17, 2026-- Higher p-tau217 levels are associated with an increased risk for progression to cognitive impairment and accelerated cognitive decline among cognitively unimpaired older adults, according to a study published online July 14...
Read more »

Pharmaceutical news



2015 to 2023 Saw Decline in Health Care-Associated Infections in the U.S.
More Weight Loss Reported With Dexamphetamine Versus Methylphenidate for ADHD
AAIC: Blood-Based Biomarkers for Alzheimer Disease Improve Accuracy of Diagnosis
Peptide Vaccine Targeting KRAS Mutations Promising for Pancreatic Ductal Adenocarcinoma
Seniors Undergoing High-Risk Emergency General Surgery Have Fewer Healthy Days at Home
Tobacco Treatment Program Effective in Oncology Settings
CDC Warns Of Parasite Outbreak Tied To Taco Bell Lettuce In 5 States
The Best Vegetables For Your Heart May Depend On Your Sex
Black Americans Born Abroad Have Lower Odds For Stroke, Study Finds
A Hidden Influence On Teen Girls' Emotions: Testosterone
One Type Of ADHD Med May Affect Kids' Weight
Poll: Many Older Americans Unaware Of 988 Suicide Help Line
A Sales Tax On Doctor Visits And Medicine? In Missouri, Some Worry
Odds of Stroke Lower Among Black Individuals Who Have Immigrated
Desktop versie